Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Genomics and genome editing in the NHS inquiry

Home All news & events News Genomics and genome editing in the NHS…

The UK Parliament’s Science and Technology Committee recently completed an examination of the UK Chief Medical Officer’s (Dame Sally Davies) call in her 2016 annual report, ‘Generation Genome’, for mainstreaming genomic medicine in the NHS within 5 years.

The Committee considered the conclusions from an interim report from the previous Committee on Genomics and gene-editing and sought submissions on observations of how any barriers to greater integration of genomic therapies in the NHS could be overcome.

The ‘Genomics and genome editing in the NHS’ Report of the inquiry, released on 20 April 2018, reported that the deployment of the UK’s world-leading genomics capabilities in the NHS is being held back by NHS digital infrastructure delays and reduced training budgets, and risks losing public support due to low public awareness of the benefits on offer. The report also calls for the Concordat and Moratorium agreed between the Government and the Association of 20 British Insurers, which prohibits insurers from basing premiums on predictive genetic information, be renewed.

The full report is available at here.


More news

Couple with two young children, smiling at the baby on the mother's knee

Grants for Genomic Implementation Projects

Australian Genomics has funded eight new projects as part of its Genomic Implementation Projects grant...

May 30, 2022

Read More >

Mitochondrial cells

Mitochondrial donation now legal in Australia

The historic passing of the Mitochondrial Donation Law Reform (Maeve’s Law) Bill by the Australian...

March 31, 2022

Read More >

Group of young children with hands clasped together in the air

New national agency to advance genomic medicine welcomed

Australian Genomics Lead Professor Kathryn North says a new national agency to support genomic medicine...

March 20, 2022

Read More >


Connect with us

(03) 9936 6345
info@australiangenomics.org.au
50 Flemington Road, Parkville
Victoria 3052 Australia

In the spirit of reconciliation Australian Genomics acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

To stay informed about our work, sign up to our newsletter

Subscribe

Quicklinks

  • Home
  • What we do
  • What we offer
  • Tools & resources
  • Our publications
  • Our project areas
  • Research we’re supporting
  • Our team

Privacy

  • We follow the Australian Privacy Principles
  • General privacy policy
  • Website privacy policies
  • Terms & conditions

Website by Blueboat.